
PGIMER Admit Card 2020 Released: As per the latest update, the PGIMER 2020 Admit Card has been released for the candidates who have joined for PhD, M.SC/MLT and Postdoctoral Fellowship programmes starting in January 2020. The Post Graduate Institute of Medical Education & Research, Chandigarh (PGIMER) has released the admit cards or hall tickets for the upcoming exams on its official website. Candidates can download PGIMER Admit Card 2020 for PhD, M.SC/MLT, Fellowship programmes online by logging onto website pgimer.edu.in. Alternatively, a direct link to Download PGIMER Admit Card 2020 for January Session has been provided below, which will take candidates directly to the admit card download page.
Download PIGMER Admit Card 2020 (PhD, M.SC/MLT, Fellowships) – Direct Link
Admit Card Available Through Login
Keeping in mind the security of the details of candidates provided in the PGIMER 2020 Admit Card, they have been made available to the students online only through login process. Therefore, candidates need to keep their login credentials ready in advance to be able to download the admit card easily, without any delays or facing problems. In case, you have forgotten the password to PGIMER 2020 exam portal, the website also have an option to reset the password.
PGIMER 2020 Helpline Details
Candidates must note that the PGIMER 2020 Admit Cards have been issued only to those candidates who have completed the application process completely along with the payment of application fee. If any such candidates have not been issued admit card or are unable to download it, they are advised to get in touch with the PGIMER 2020 helpdesk. Even those candidates who have downloaded their PGIMER 2020 admit card but have errors or mistakes, can also get in touch with the helpline to resolve their queries. The details of PGIMER 2020 helpline are provided below:
- Helpline No -022-61306243 ,
- Helpdesk Email ID – mdmsjan2020@gmail.com
- PGIMER Email id – pgimdmsexam@gmail.com
- PGIMER Office Helpline No – 0172-2755562

Comments
All Comments (0)
Join the conversation